Association of body mass index with clinical outcome of primary WHO grade 4 glioma

Autor: Jiejun Wang, Zhaonian Hao, Ruyuan Li, Weiqi Wu, Na Huang, Kangna Zhang, Shuyu Hao, Jie Feng, Junsheng Chu, Nan Ji

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

BackgroundThe prognostic value of body mass index (BMI) in primary WHO grade 4 gliomas is not widely acknowledged. This study aims to assess the survival outcomes of patients with different BMIs.MethodsReal-world data of patients diagnosed with prima

Externí odkaz: https://doaj.org/article/880a61af73a24e05ac23682370e25c0c

Impact of WeChat guidance on bowel preparation for colonoscopy: a quasi-experiment study

Autor: Yifang Guan, Yanjun Song, Xiaona Li, Aijun Zhang, Ruyuan Li

Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-5 (2023)

Abstract Colonoscopy is a standard procedure for screening, monitoring, and treating colorectal lesions. To explore the impact of WeChat guidance on bowel preparation before colonoscopy. This quasi-experiment study included patients who underwent col

Externí odkaz: https://doaj.org/article/7a686bccfc464e5abac10e386e9415b4

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy

Autor: Zhaonian Hao, Ruyuan Li, Yuanyuan Wang, Shuangying Li, Zhenya Hong, Zhiqiang Han

Publikováno v: Biomarker Research, Vol 9, Iss 1, Pp 1-28 (2021)

Abstract Myeloid-derived suppressor cells (MDSC) are a group of immature cells that produced by emergency myelopoiesis. Emerging evidences have identified the vital role of MDSC in cancer microenvironment, in which MDSC exerts both immunological and

Externí odkaz: https://doaj.org/article/e9b6aabb2c6c4539949200b839f6087f

Sintilimab combined with bevacizumab in relapsed/persistent ovarian clear cell carcinoma (INOVA): an investigator-initiated, multicentre clinical trial—a study protocol of clinical trial

Autor: Yang Yu, Wei Zhang, Guiling Li, Ming Li, Xingyu Liu, Jie Jiang, Yingjun Zhao, Ruyuan Li, Chunyan Song, Jiahao Liu, Xiaofei Jiao, Shaoqing Zeng, Jianhua Chi, Guanchen Ma, Yabing Huo, Zikun Peng, Qing-Lei Gao

Publikováno v: BMJ Open, Vol 12, Iss 5 (2022)

Background Ovarian clear cell carcinoma (OCCC) has an abysmal prognosis with a median overall survival (OS) of 25.3 months because of a low response to chemotherapy. The 5-year disease-specific survival rate after recurrence is 13.2%, with more than

Externí odkaz: https://doaj.org/article/0d86fbdd3d5945bcaa3bfa99a1f50c0f

Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study

Autor: Yue Gao, MD, Shaoqing Zeng, MD, Xiaoyan Xu, ProfMD, Huayi Li, Shuzhong Yao, ProfPhD, Kun Song, ProfPhD, Xiao Li, BS, Lingxi Chen, PhD, Junying Tang, ProfPhD, Hui Xing, ProfPhD, Zhiying Yu, ProfPhD, Qinghua Zhang, ProfPhD, Shue Zeng, ProfPhD, Cunjian Yi, ProfPhD, Hongning Xie, ProfPhD, Xiaoming Xiong, BS, Guangyao Cai, MD, Zhi Wang, MS, Yuan Wu, MS, Jianhua Chi, BS, Xiaofei Jiao, BS, Yan Qin, MS, Xiaogang Mao, MD, Yu Chen, MD, Xin Jin, MD, Qingqing Mo, MD, Pingbo Chen, ProfMD, Yi Huang, ProfMD, Yushuang Shi, MD, Junmei Wang, ProfPhD, Yimin Zhou, MD, Shuping Ding, MD, Shan Zhu, MD, Xin Liu, ProfMD, Xiangyi Dong, MD, Lin Cheng, MD, Linlin Zhu, MD, Huanhuan Cheng, MD, Li Cha, MD, Yanli Hao, MS, Chunchun Jin, MD, Ludan Zhang, MD, Peng Zhou, BS, Meng Sun, MS, Qin Xu, MS, Kehua Chen, BS, Zeyan Gao, MS, Xu Zhang, BS, Yuanyuan Ma, MS, Yan Liu, MD, Liling Xiao, MS, Li Xu, MD, Lin Peng, BS, Zheyu Hao, MD, Mi Yang, MD, Yane Wang, MD, Hongping Ou, MD, Yongmei Jia, MD, Lihua Tian, MD, Wei Zhang, MD, Ping Jin, MS, Xun Tian, ProfMD, Lei Huang, MD, Zhen Wang, MD, Jiahao Liu, BS, Tian Fang, MS, Danmei Yan, BS, Heng Cao, BS, Jingjing Ma, MD, Xiaoting Li, MD, Xu Zheng, BS, Hua Lou, BS, Chunyan Song, BS, Ruyuan Li, BS, Siyuan Wang, BS, Wenqian Li, MD, Xulei Zheng, MD, Jing Chen, MD, Guannan Li, BS, Ruqi Chen, MS, Cheng Xu, MS, Ruidi Yu, MS, Ji Wang, MS, Sen Xu, MD, Beihua Kong, ProfPhD, Xing Xie, ProfPhD, Ding Ma, ProfPhD, Qinglei Gao, ProfPhD

Publikováno v: The Lancet: Digital Health, Vol 4, Iss 3, Pp e179-e187 (2022)

Summary: Background: Ultrasound is a critical non-invasive test for preoperative diagnosis of ovarian cancer. Deep learning is making advances in image-recognition tasks; therefore, we aimed to develop a deep convolutional neural network (DCNN) model

Externí odkaz: https://doaj.org/article/557389c903e04fe284a592be5931df32